These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. Bayard S; Langenier MC; Dauvilliers Y Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease. Holtz NA; Tedford SE; Persons AL; Grasso SA; Napier TC Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():77-84. PubMed ID: 27216282 [TBL] [Abstract][Full Text] [Related]
6. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease. Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Oregi A; Belloso-Iguerategui A; Delgado-Alvarado M; Navalpotro-Gómez I; Marin C; Fernagut PO; Rodríguez-Oroz MC Neurobiol Aging; 2019 Mar; 75():126-135. PubMed ID: 30572183 [TBL] [Abstract][Full Text] [Related]
7. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors. Claassen DO; Stark AJ; Spears CA; Petersen KJ; van Wouwe NC; Kessler RM; Zald DH; Donahue MJ Mov Disord; 2017 Nov; 32(11):1574-1583. PubMed ID: 28627133 [TBL] [Abstract][Full Text] [Related]
8. Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats. Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Delgado-Alvarado M; Navalpotro-Gómez I; Belloso-Iguerategui A; Marin C; Rodríguez-Oroz MC Psychopharmacology (Berl); 2020 Aug; 237(8):2419-2431. PubMed ID: 32440779 [TBL] [Abstract][Full Text] [Related]
9. The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting. Floris G; Scheggi S; Pes R; Bortolato M Brain Res Bull; 2022 Apr; 181():157-166. PubMed ID: 35122898 [TBL] [Abstract][Full Text] [Related]
10. Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networks. Magnard R; Fouyssac M; Vachez YM; Cheng Y; Dufourd T; Carcenac C; Boulet S; Janak PH; Savasta M; Belin D; Carnicella S Transl Psychiatry; 2024 Feb; 14(1):86. PubMed ID: 38336862 [TBL] [Abstract][Full Text] [Related]
11. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease. Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460 [TBL] [Abstract][Full Text] [Related]
12. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Guttman M; Stewart D; Hussey D; Wilson A; Houle S; Kish S Neurology; 2001 Jun; 56(11):1559-64. PubMed ID: 11402115 [TBL] [Abstract][Full Text] [Related]
13. Nigrostriatal and Mesolimbic D Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278 [TBL] [Abstract][Full Text] [Related]
14. Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum. Yasuda K; Abe H; Koganemaru G; Ikeda T; Arimori K; Ishida Y Pharmacol Biochem Behav; 2015 Apr; 131():1-5. PubMed ID: 25622778 [TBL] [Abstract][Full Text] [Related]
15. Cocaine-specific neuroplasticity in the ventral striatum network is linked to delay discounting and drug relapse. Contreras-Rodríguez O; Albein-Urios N; Perales JC; Martínez-Gonzalez JM; Vilar-López R; Fernández-Serrano MJ; Lozano-Rojas O; Verdejo-García A Addiction; 2015 Dec; 110(12):1953-62. PubMed ID: 26212416 [TBL] [Abstract][Full Text] [Related]
16. Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease. Loiodice S; McGhan P; Gryshkova V; Fleurance R; Dardou D; Hafidi A; Nogueira da Costa A; Durif F J Psychopharmacol; 2017 Oct; 31(10):1323-1333. PubMed ID: 28631520 [TBL] [Abstract][Full Text] [Related]
17. Aged monkeys as a partial model for Parkinson's disease. Hurley PJ; Elsworth JD; Whittaker MC; Roth RH; Redmond DE Pharmacol Biochem Behav; 2011 Sep; 99(3):324-32. PubMed ID: 21620883 [TBL] [Abstract][Full Text] [Related]
18. Dopaminergic function and intertemporal choice. Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841 [TBL] [Abstract][Full Text] [Related]
19. Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy. Engeln M; Ansquer S; Dugast E; Bezard E; Belin D; Fernagut PO Neuropharmacology; 2016 Oct; 109():69-77. PubMed ID: 27216859 [TBL] [Abstract][Full Text] [Related]
20. Effects of pramipexole on impulsive choice in male wistar rats. Madden GJ; Johnson PS; Brewer AT; Pinkston JW; Fowler SC Exp Clin Psychopharmacol; 2010 Jun; 18(3):267-76. PubMed ID: 20545391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]